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Objective
To assess and compare functional ability, as measured by
the Childhood Health Assessment Questionnaire (C-
HAQ), in juvenile idiopathic arthritis (JIA), juvenile der-
matomyositis (JDM), juvenile systemic lupus erythemato-
sus (JSLE) and healthy controls.
Methods
Patients with active JIA, JDM and JSLE, C-HAQ availability
and less than 18 years were compared to healthy children.
All patients were also evaluated for demographic and dis-
ease activity parameters at baseline and after 6 months.
Results
4,624 subjects (613 JIA, 277 JDM, 531 JSLE, and 3,203
healthy children) were included. Baseline functional disa-
bility was higher in patients with JDM (mean ± SD C-HAQ
1.7 ± 0.9), followed by JIA (1.2 ± 0.8 JIA), and JSLE (0.8 ±
0.9) and healthy control (0.1 ± 0.3). The C-HAQ score
correlated moderately with the physical well being scale of
the Child Health Questionnaire (CHQ PhS) for all 3 dis-
eases and with the number of active joints in JIA, and with
the Disease Activity Score (DAS) in JDM and poorly with
JSLE disease activity variables. Common predictors of per-
sistence of poor functional ability (C-HAQ ≥ 1.27, ≥ 1, ≥
0.25 for JIA, JDM and JSLE respectively) were poor base-
line C-HAQ and younger age at onset; other predictors
were ANA negativity, and low CHQ-PhS for JIA, higher
JSLE disease activity, and poor CHQ PhS and longer dis-
ease duration for JDM.
Conclusion
Baseline functional ability was poorer in active JDM than
in JIA, and JSLE. A poor baseline C-HAQ and younger age
at onset are predictors of persistence of poor functional
ability despite treatment in either JIA, JDM and JSLE.
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